Vnitr Lek 2012, 58(Suppl 2):61-64

Emergency situations in hematology

M. Marková
Ústav hematologie a krevní transfuze Praha, ředitel prof. MUDr. Marek Trněný, CSc.

Both the development of new therapeutic strategies and intensification of the treatment of haematologic patients lead to increasing number of emergencies that must be immediately resolved. Some of these complications may be specific for this type of patients and they frequently occur at the time diagnosis and initial therapy. Although this type of treatment is usually provided in hematologic centers, the patients often need primary care immediately when complication appears. The paper should shortly outline the specific problems of these cases.

Keywords: tumor lysis syndrome; hyperleukocytic syndrome; hyperviscosity syndrome; hypercalcemia; SIADH; vena cava superior syndrome; neutropenic fever

Received: May 28, 2012; Published: April 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marková M. Emergency situations in hematology. Vnitr Lek. 2012;58(Supplementum 2):61-64.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pession A, Masetti R, Gaidano G et al. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel. Adv Ther 2011; 28: 684-697. Go to original source... Go to PubMed...
    2. Coiffier B, Altman A, Pui CH et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008; 26: 2767-2778. Go to original source... Go to PubMed...
    3. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med 2011; 364: 1844-1854. Go to original source... Go to PubMed...
    4. Clines GA. Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obes 2011; 18: 339-346. Go to original source... Go to PubMed...
    5. Sargent JT, Smith OP. Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders. Br J Haematol 2010; 149: 465-477. Go to original source... Go to PubMed...
    6. Rudnay M, Hrabčáková P, Lazúrová I. Hyponatriémia při syndróme neprimeranej sekrécie vazopresinu (SIADH) - možnosti léčby. Vnitř Lék 2012; 58: 52-55. Go to PubMed...
    7. Esposito P, Piotti G, Bianzina S et al. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract 2011; 119: c62-c73. Go to original source... Go to PubMed...
    8. Porcu P, Cripe LD, Ng EW et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000; 39: 1-18. Go to original source... Go to PubMed...
    9. Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood 2012; 119: 2205-2208. Go to original source... Go to PubMed...
    10. Schraufnagel DE, Hill R, Leech JA et al. Superior vena caval obstruction. Is it a medical emergency? Am J Med 1981; 70: 1169-1174. Go to original source... Go to PubMed...
    11. Ahmann FR. A reassessment of the clinical implications of the superior vena caval syndrome. J Clin Oncol 1984; 2: 961-969. Go to original source... Go to PubMed...
    12. Ribas ES, Schiff D. Spinal cord compression. Curr Treat Options Neurol 2012; 14: 391-401. Go to original source... Go to PubMed...
    13. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005; 6: 15-24. Go to original source...
    14. Lyman GH, Kuderer NM, Crawford J et al. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer 2011; 117: 1917-1927. Go to original source... Go to PubMed...
    15. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751. Go to original source... Go to PubMed...
    16. Franchini M, Mannucci PM. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice. Br J Clin Pharmacol 2011; 72: 553-562. Go to original source... Go to PubMed...
    17. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1935. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.